The PE Ratio as of December 2024 (TTM) for Amicus Therapeutics, Inc. (FOLD) is -28.79

According to Amicus Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -28.79. This represents a change of -47.04% compared to the average of -54.37 of the last 4 quarters.

Amicus Therapeutics, Inc. (FOLD) Historical PE Ratio (quarterly & annually)

How has FOLD PE Ratio performed in the past?

The mean historical PE Ratio of Amicus Therapeutics, Inc. over the last ten years is -11.65. The current -28.79 PE Ratio has changed 24.61% with respect to the historical average. Over the past ten years (40 quarters), FOLD's PE Ratio was at its highest in in the December 2016 quarter at -2.85. The PE Ratio was at its lowest in in the September 2024 quarter at -120.90.

Amicus Therapeutics, Inc. (FOLD) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Amicus Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Amicus Therapeutics, Inc. (FOLD) Average PE Ratio

How has FOLD PE Ratio performed in the past?

The current PE Ratio of Amicus Therapeutics, Inc. (FOLD) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Amicus Therapeutics, Inc. (FOLD) PE Ratio vs. Peers

How is FOLD’s PE Ratio compared to its peers?

Amicus Therapeutics, Inc.’s PE Ratio is less than Incyte Corporation (414.59), less than Denali Therapeutics Inc. (-8.29), greater than argenx SE (-371.18), less than Harmony Biosciences Holdings, Inc. (15.80), less than Ultragenyx Pharmaceutical Inc. (-7.47), less than Crinetics Pharmaceuticals, Inc. (-15.54), less than Arvinas, Inc. (-4.38), less than Revolution Medicines, Inc. (-13.06), less than Kura Oncology, Inc. (-3.90), less than Mineralys Therapeutics, Inc. (-4.16), less than Legend Biotech Corporation (-17.16), less than Cytokinetics, Incorporated (-9.91), less than Inhibrx Biosciences, Inc. (0.14), less than DICE Therapeutics, Inc. (-22.94), less than Edgewise Therapeutics, Inc. (-22.36), greater than Karuna Therapeutics, Inc. (-37.08), less than Dyne Therapeutics, Inc. (-8.21), less than Mereo BioPharma Group plc (-13.89), greater than Blueprint Medicines Corporation (-44.77), less than Agios Pharmaceuticals, Inc. (2.89), less than Day One Biopharmaceuticals, Inc. (-14.52), less than BioMarin Pharmaceutical Inc. (39.37),

Build a custom stock screener for Amicus Therapeutics, Inc. (FOLD) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Amicus Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Amicus Therapeutics, Inc. (FOLD) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Amicus Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.